Approval · Notice of Compliance 30136 · 2023
ELLA: Notice of Compliance 30136
Issued February 16, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30136
- Date
- February 16, 2023
- Company
- Laboratoire Hra PharmaChâtillon, --, France
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety updates to the Product Monograph. Product Monograph reformatted to the master template.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ELLA | Not yet assigned | — |
Medicinal ingredients
- ULIPRISTAL ACETATE 30 MG per TAB